Susquehanna Fundamental Investments, LLC Gamida Cell Ltd. Transaction History

Susquehanna Fundamental Investments, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$1.53 - $3.39 $195,220 - $432,547	-127,595 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$2.22 - $4.47 $15,244 - $30,695	-6,867 Reduced 5.11%	127,595 $530,000
Q4 2021 Feb 14, 2022	SELL	$2.2 - $4.46 $17,232 - $34,935	-7,833 Reduced 5.5%	134,462 $342,000
Q3 2021 Nov 15, 2021	BUY	$3.85 - $6.44 $547,835 - $916,379	142,295 New	142,295 $558,000
Q2 2021 Aug 11, 2021	SELL	$5.85 - $8.33 $62,594 - $89,131	-10,700 Closed	0 $0

Q2 2020 Aug 14, 2020	BUY	$2.79 - $6.5 $29,853 - $69,550	10,700 New	10,700 $49,000

11.4M

235K

70.5K

Ticker GMDA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 76,319,600
Market Cap $2.29M
Description
Gamida Cell Ltd., a clinical-stage biopharmaceutical company, develops cell therapies to cure blood cancers and serious hematologic diseases. The company's lead product candidate is omidubicel, a cell therapy that has completed Phase III clinical trial in patients with high-risk hematologic malignancies, as well as in Phase I/II clinical trials ...

Get notified when there are updates to the investment portfolio of Susquehanna Fundamental Investments, LLC, based on Form 13F filings with the SEC.

Stay updated on Susquehanna Fundamental Investments, LLC with notifications on news.